Herbal drug to fight HIV

- Last updated on GMT

Related tags: Pharmacology

Indian company Bal Pharma has begun a clinical study of an anti-HIV
herbal drug developed by an ayurvedic company in the country.

Indian company Bal Pharma has begun a clinical study of an anti-HIV herbal drug developed by an ayurvedic company in Kerala, according to India's Financial Express​.

The drug is expected to be launched in the next six months, if the results from the clinical tests prove positive.

Administering the drug prevents an HIV patient from reaching the AIDS level, Bal Pharma vice-president (marketing) VR Kannan said.

Bal Pharma is the sole bulk drug manufacturer of the popular anti-diabetic drug Gliclazide in India.

During the current fiscal year, the company expects to post a net profit of Rs50 million (€1.08m) with a turnover of Rs800 million (€17.4m). Last year, the company posted a net profit of Rs10.93 million.

The company is also in talks with a US company to import DNA recombinant human insulin to cater for the Indian insulin market, Mr Kannan said.

Related news

Related products

show more

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

Total Solutions for Cognitive Health by Lubrizol

Total Solutions for Cognitive Health by Lubrizol

Lipofoods, a Lubrizol Company | 05-May-2022 | Technical / White Paper

Globally, health and wellbeing have shifted from a focus on physical health and nutrition to also include cognitive and mental wellness, therefore consumers...

Mediterranean Nutraceutical products

Mediterranean Nutraceutical products

Esserre Pharma | 19-Apr-2022 | Product Brochure

From the best Mediterranean ingredients to effective and safe finished products, Esserre Pharma researches and develops unique formulations.

Related suppliers

Follow us

Products

View more

Webinars